Therapex Co., Ltd
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients (NCT06186076) | Therapex Co., Ltd | 2024-06-14 |
Track Therapex Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.